265 related articles for article (PubMed ID: 32089234)
21. A novel antidiabetic therapy: free fatty acid receptors as potential drug target.
Sekiguchi H; Kasubuchi M; Hasegawa S; Pelisch N; Kimura I; Ichimura A
Curr Diabetes Rev; 2015; 11(2):107-15. PubMed ID: 25732031
[TBL] [Abstract][Full Text] [Related]
22. Marine Algae as a Potential Source for Anti-Obesity Agents.
Wan-Loy C; Siew-Moi P
Mar Drugs; 2016 Dec; 14(12):. PubMed ID: 27941599
[TBL] [Abstract][Full Text] [Related]
23. Epigallocatechin Gallate Modulates Muscle Homeostasis in Type 2 Diabetes and Obesity by Targeting Energetic and Redox Pathways: A Narrative Review.
Casanova E; Salvadó J; Crescenti A; Gibert-Ramos A
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30691224
[TBL] [Abstract][Full Text] [Related]
24. Targeting AMPK: From Ancient Drugs to New Small-Molecule Activators.
Guigas B; Viollet B
Exp Suppl; 2016; 107():327-350. PubMed ID: 27812986
[TBL] [Abstract][Full Text] [Related]
25. Hypothalamic AMPK: a canonical regulator of whole-body energy balance.
López M; Nogueiras R; Tena-Sempere M; Diéguez C
Nat Rev Endocrinol; 2016 Jul; 12(7):421-32. PubMed ID: 27199291
[TBL] [Abstract][Full Text] [Related]
26. Antidiabetic Potential of Green Seaweed Enteromorpha prolifera Flavonoids Regulating Insulin Signaling Pathway and Gut Microbiota in Type 2 Diabetic Mice.
Yan X; Yang C; Lin G; Chen Y; Miao S; Liu B; Zhao C
J Food Sci; 2019 Jan; 84(1):165-173. PubMed ID: 30569533
[TBL] [Abstract][Full Text] [Related]
27. Application of seaweeds to develop new food products with enhanced shelf-life, quality and health-related beneficial properties.
Roohinejad S; Koubaa M; Barba FJ; Saljoughian S; Amid M; Greiner R
Food Res Int; 2017 Sep; 99(Pt 3):1066-1083. PubMed ID: 28865618
[TBL] [Abstract][Full Text] [Related]
28. Seaweed as a source of novel nutraceuticals: sulfated polysaccharides and peptides.
Jiménez-Escrig A; Gómez-Ordóñez E; Rupérez P
Adv Food Nutr Res; 2011; 64():325-37. PubMed ID: 22054959
[TBL] [Abstract][Full Text] [Related]
29. G protein-coupled receptors as therapeutic targets for obesity and type 2 diabetes.
Bjenning C; Al-Shamma H; Thomsen W; Leonard J; Behan D
Curr Opin Investig Drugs; 2004 Oct; 5(10):1051-62. PubMed ID: 15535426
[TBL] [Abstract][Full Text] [Related]
30. Marine Peptides as Potential Agents for the Management of Type 2 Diabetes Mellitus-A Prospect.
Xia EQ; Zhu SS; He MJ; Luo F; Fu CZ; Zou TB
Mar Drugs; 2017 Mar; 15(4):. PubMed ID: 28333091
[TBL] [Abstract][Full Text] [Related]
31. Seaweed and seaweed-derived metabolites as prebiotics.
Charoensiddhi S; Abraham RE; Su P; Zhang W
Adv Food Nutr Res; 2020; 91():97-156. PubMed ID: 32035602
[TBL] [Abstract][Full Text] [Related]
32. The effects of incretins on energy homeostasis: physiology and implications for the treatment of type 2 diabetes mellitus and obesity.
Karras S; Goulis DG; Mintziori G; Katsiki N; Tzotzas T
Curr Vasc Pharmacol; 2012 Nov; 10(6):781-91. PubMed ID: 22272906
[TBL] [Abstract][Full Text] [Related]
33. Seaweeds as Nutraceutical Elements and Drugs for Diabetes Mellitus: Future Perspectives.
Cotas J; Lomartire S; Pereira L; Valado A; Marques JC; Gonçalves AMM
Mar Drugs; 2024 Apr; 22(4):. PubMed ID: 38667785
[TBL] [Abstract][Full Text] [Related]
34. Bioactive Polyphenols from Southern Chile Seaweed as Inhibitors of Enzymes for Starch Digestion.
Pacheco LV; Parada J; Pérez-Correa JR; Mariotti-Celis MS; Erpel F; Zambrano A; Palacios M
Mar Drugs; 2020 Jul; 18(7):. PubMed ID: 32650394
[TBL] [Abstract][Full Text] [Related]
35. Hesperidin: A Therapeutic Agent For Obesity.
Xiong H; Wang J; Ran Q; Lou G; Peng C; Gan Q; Hu J; Sun J; Yao R; Huang Q
Drug Des Devel Ther; 2019; 13():3855-3866. PubMed ID: 32009777
[TBL] [Abstract][Full Text] [Related]
36. The entero-insular axis: implications for human metabolism.
Ranganath LR
Clin Chem Lab Med; 2008; 46(1):43-56. PubMed ID: 18020966
[TBL] [Abstract][Full Text] [Related]
37. Antioxidant and Signal-Modulating Effects of Brown Seaweed-Derived Compounds against Oxidative Stress-Associated Pathology.
Begum R; Howlader S; Mamun-Or-Rashid ANM; Rafiquzzaman SM; Ashraf GM; Albadrani GM; Sayed AA; Peluso I; Abdel-Daim MM; Uddin MS
Oxid Med Cell Longev; 2021; 2021():9974890. PubMed ID: 34336128
[TBL] [Abstract][Full Text] [Related]
38. New insights into seaweed polyphenols on glucose homeostasis.
Murugan AC; Karim MR; Yusoff MB; Tan SH; Asras MF; Rashid SS
Pharm Biol; 2015 Aug; 53(8):1087-97. PubMed ID: 25630358
[TBL] [Abstract][Full Text] [Related]
39. Phenolic Compounds from Edible Algae: Bioactivity and Health Benefits.
Montero L; Del Pilar Sánchez-Camargo A; Ibáñez E; Gilbert-López B
Curr Med Chem; 2018; 25(37):4808-4826. PubMed ID: 28545377
[TBL] [Abstract][Full Text] [Related]
40. Potential Antidiabetic Effects of Seaweed Extracts by Upregulating Glucose Utilization and Alleviating Inflammation in C2C12 Myotubes.
Kim E; Cui J; Kang I; Zhang G; Lee Y
Int J Environ Res Public Health; 2021 Feb; 18(3):. PubMed ID: 33540936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
